Search for: "Pharm-Save, Inc." Results 21 - 40 of 56
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jan 2015, 8:19 pm by Schachtman
Merrell Dow Pharms., Inc., 911 F.2d 941 (3d Cir. 1990). [read post]
13 Aug 2010, 12:46 pm
See King Pharms., Inc., 593 F. [read post]
3 Oct 2010, 10:16 pm by John Watts & M. Stan Herring
Lifelock was recently voted 8th overall and #1 in security in INC Magazine's top-growing 500 companies. [read post]
3 May 2010, 8:03 pm by Two-Seventy-One Patent Blog
  However, the court interpreted Bilski to mean that the “machine-or-transformation test” is the sole test to determine the patent eligibility of method claims.King Pharms., Inc. v. [read post]
5 Jun 2013, 5:29 am by Schachtman
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
21 Dec 2012, 11:41 am by Bexis
”  The only saving grace is that the Louisiana Supreme Court might think so too. [read post]
4 Aug 2012, 9:14 am by Schachtman
Merrell Dow Pharms., Inc., 874 F.2d 307, 312 , modified on reh’g, 884 F.2d 166 (5th Cir. 1989)). [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  As described below, we surveyed all biotech securities class actions in the past five years to better understand how they have fared in the federal courts, and once again found that they were actually more likely than other types of cases to be dismissed early in the litigation, saving defendants (and insurers) from the bulk of potential legal costs. [read post]
17 Dec 2007, 4:14 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993), which requires that district courts act as "gatekeepers" concerning the admissibility of evidence - does not apply at the class certification stage. [read post]